EDIT: Editas Medicine, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | New 13G stake | ADAR1 Capital Management, LLC | 5.80% | SEC | |
| 2026-07-29 | Fell below 5% | BlackRock, Inc. | 4.97% | SEC |
Institutional ownership (Q2 2026)
216 institutions reported holding $383.39M of Editas Medicine, Inc. on Form 13F (208 the quarter before). 35 opened a new position and 25 sold out. Shares held by institutions: +132%.
| Largest holders | Shares | Value |
|---|---|---|
| TCG Crossover Management, LLC | 11,111,111 | $36.00M |
| BlackRock, Inc. | 10,589,990 | $34.31M |
| RA CAPITAL MANAGEMENT, L.P. | 8,889,000 | $28.80M |
| Commodore Capital LP | 8,889,000 | $28.80M |
| ADAR1 Capital Management, LLC | 8,889,000 | $28.80M |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,141,336 | $19.90M |
| Paradigm Biocapital Advisors LP | 5,586,625 | $18.10M |
| Opaleye Management Inc. | 3,861,930 | $12.51M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,598,339 | $11.66M |
| Woodline Partners LP | 3,555,497 | $11.52M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.